Ring Therapeutics Funding & Investors
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.
ringtx.comTotal Amount Raised: $253,500,000
Ring Therapeutics Funding Rounds
Series B
$117,000,000
Series B Investors
Flagship PioneeringInvusT. Rowe PriceAltitude Life Science VenturesPartners InvestmentUPMC EnterprisesSeries Unknown
$50,000,000
Series Unknown Investors
Flagship PioneeringSeries C
$86,500,000
Series C Investors
Kyowa Kirin Co.InvusAlexandria Venture InvestmentsT. Rowe PricePartners InvestmentCJ InvestmentUPMC EnterprisesFlagship PioneeringAltitude Life Science Ventures
Funding info provided by Diffbot.